Skip to content

DR. E. FLIES

Dissolution or liquidation
Private limited companyfounded 2008Generaal Lemanstraat 70, 2600 Antwerpen, BelgiumKBO/BCE: BE 0898.963.831

The KBO register records for DR. E. FLIES the legal situation: dissolution or liquidation; this is today's state according to the register itself, which carries no start date. Dissolved on 31-07-2026, in liquidation; liquidator: FLIES Emeric Alfred Lydia Noël, formerly director.

Summary

The 2025 annual accounts show equity of €685,619 and a net result of €79,570.

DR. E. FLIESDissolution or liquidation

Signals

Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Register: dissolution or liquidation
The KBO register records the legal situation: dissolution or liquidation. This is today's state according to the register itself; the register carries no start date.
KBO · legal situation
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
23 d early
2024
29 d late
2023
9 d early
2022
2 d late
2021
37 d late
2020
110 d late
2019
25 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 24 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

DR. E. FLIES was incorporated on 30 June 2008.1 Since 2026, FLIES Emeric Alfred Lydia Noël has served as liquidator of the company.2 Total assets rose from EUR 134,904 in 2018 to EUR 686,452 in 2025.3 In 2026 the company was dissolved and put into liquidation.2

  1. 1Crossroads Bank for Enterprises
  2. 2Belgian State Gazette, 19-08-2026
  3. 3National Bank, annual accounts 2018 and 2025

Go further with this company

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€685,619▲ 13.1%
2024 · €606,049
Total assets
€686,452▲ 12.4%
2024 · €610,656
Net result
€79,570▼ 24.4%
2024 · €105,203
Working capital
€652,950▲ 11.2%
2024 · €587,198
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.

Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€131,369▲ 69.9%€114,825▼ 12.6%€176,139▲ 53.4%€151,216▼ 14.1%€114,015▼ 24.6%
Net result€94,227within the sector's middle half▲ 65.4%€84,459within the sector's middle half▼ 10.4%€120,014above the sector's middle half▲ 42.1%€105,203within the sector's middle half▼ 12.3%€79,570within the sector's middle half▼ 24.4%
Equity€296,374within the sector's middle half▲ 26.3%€380,833above the sector's middle half▲ 28.5%€500,846above the sector's middle half▲ 31.5%€606,049above the sector's middle half▲ 21.0%€685,619above the sector's middle half▲ 13.1%
Total assets€335,215within the sector's middle half▲ 36.7%€384,046within the sector's middle half▲ 14.6%€505,837within the sector's middle half▲ 31.7%€610,656within the sector's middle half▲ 20.7%€686,452above the sector's middle half▲ 12.4%
Debt€38,841▲ 270%€3,213▼ 91.7%€4,991▲ 55.3%€4,607▼ 7.7%€833▼ 81.9%
Working capital€266,523above the sector's middle half▲ 24.8%€355,776above the sector's middle half▲ 33.5%€477,696above the sector's middle half▲ 34.3%€587,198above the sector's middle half▲ 22.9%€652,950above the sector's middle half▲ 11.2%
Solvency88.4%above the sector's middle half▼ 7.3pp99.2%above the sector's middle half▲ 10.8pp99.0%above the sector's middle half▼ 0.1pp99.2%above the sector's middle half▲ 0.2pp99.9%above the sector's middle half▲ 0.6pp
Current ratio7.86above the sector's middle half▼ 13.4996.71above the sector's middle half
Return on assets (ROA)28.1%within the sector's middle half▲ 4.9pp22.0%within the sector's middle half▼ 6.1pp23.7%within the sector's middle half▲ 1.7pp17.2%within the sector's middle half▼ 6.5pp11.6%within the sector's middle half▼ 5.6pp
above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50,000€100,000€150,000€200,000Operating result 2021: €131,369€131,369Net result 2021: €94,227€94,227Operating result 2022: €114,825€114,825Net result 2022: €84,459€84,459Operating result 2023: €176,139€176,139Net result 2023: €120,014€120,014Operating result 2024: €151,216€151,216Net result 2024: €105,203€105,203Operating result 2025: €114,015€114,015Net result 2025: €79,570€79,57020212022202320242025€0€50,000€100,000€150,000€200,000Operating result 2023: €176,139€176,000Net result 2023: €120,014€120,000Operating result 2024: €151,216€151,000Net result 2024: €105,203€105,000Operating result 2025: €114,015€114,000Net result 2025: €79,570€79,600202320242025
The operating result has fallen two years in a row; 2025 is 25% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €686,452
Fixed assets €32,670 ▲ 73.2%
Current assets €653,783 ▲ 10.5%
Equity and liabilities €686,452
Equity €685,619 ▲ 13.1%
Debt €833 ▼ 81.9%
Debt's share of the balance-sheet total falls from 0.8% to 0.1%. Equity is higher and debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€121,386▼
2024 · €157,533
Cash flow
€86,941▼
2024 · €111,520
Debt to equity
0.00▼
2024 · 0.01
ROE
11.6%▼
2024 · 17.4%
Interest coverage
166.39▼
2024 · 205.14
Debt ≤ 1 year
€833▼
2024 · €4,593
Income taxes
€40,920▼
2024 · €50,878
A ratio outside any meaningful range has been withheld (balance sheet total €686,452, equity €685,619).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 39 lines
Balance sheet Code20242025
Assets
Total assets20/58€610,656€686,452▲
Fixed assets21/28€18,866€32,670▲
Tangible fixed assets22/27€18,866€32,670▲
Land and buildings22€14,491€30,294▲
Furniture and vehicles24€4,375€2,376▼
Current assets29/58€591,790€653,783▲
Amounts receivable within one year40/41€47,004€74,763▲
Other amounts receivable41€47,004€74,763▲
Current investments50/53€426,977€527,173▲
Cash at bank and in hand54/58€104,827€39,332▼
Deferred charges and accrued income490/1€12,983€12,515▼
Equity and liabilities
Total equity and liabilities10/49€610,656€686,452▲
Equity10/15€606,049€685,619▲
Contributions10/11€12,400€12,400=
Reserves13€593,649€673,219▲
Distributable reserves133€593,649€673,219▲
Amounts payable17/49€4,607€833▼
Amounts payable within one year42/48€4,593€833▼
Trade debts44€2,378€833▼
Suppliers440/4€2,378€833▼
Taxes, remuneration and social security45€2,215-
Taxes450/3€2,215-
Accrued charges and deferred income492/3€14-
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6,317€7,371▲
Other operating charges640/8€862€967▲
Gross operating margin9900€158,395€122,353▼
Operating profit (loss)9901€151,216€114,015▼
Financial income75/76B€5,633€7,205▲
Recurring financial income75€5,633€7,205▲
Financial charges65/66B€768€730▼
Recurring financial charges65€768€730▼
Profit (loss) for the period before taxes9903€156,081€120,490▼
Income taxes67/77€50,878€40,920▼
Profit (loss) for the period9904€105,203€79,570▼
Profit (loss) for the period to be appropriated9905€105,203€79,570▼
Appropriation of the result
Profit (loss) to be appropriated9906€105,569€79,570▼
Profit (loss) brought forward from the previous period14P€366-
Transfer to equity691/2€105,569€79,570▼
To other reserves6921€105,569€79,570▼

The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5,046€6,035€5,871€6,317€7,371▲ 16.7%
Other operating charges640/8€1,127€738€1,623€862€967▲ 12.2%
Gross operating margin9900€137,542€121,598€183,633€158,395€122,353▼ 22.8%
Operating profit (loss)9901€131,369€114,825€176,139€151,216€114,015▼ 24.6%
Financial income75/76B€2,070€3,196€1,859€5,633€7,205▲ 27.9%
Recurring financial income75€2,070€3,196€1,859€5,633€7,205▲ 27.9%
Financial charges65/66B€735€661€769€768€730▼ 5.0%
Recurring financial charges65€735€661€769€768€730▼ 5.0%
Profit (loss) for the period before taxes9903€132,704€117,360€177,229€156,081€120,490▼ 22.8%
Income taxes67/77€38,477€32,901€57,215€50,878€40,920▼ 19.6%
Profit (loss) for the period9904€94,227€84,459€120,014€105,203€79,570▼ 24.4%
Profit (loss) for the period to be appropriated9905€94,227€84,459€120,014€105,203€79,570▼ 24.4%
Line20212022202320242025Change
Assets
Total assets20/58€335,215€384,046€505,837€610,656€686,452▲ 12.4%
Fixed assets21/28€29,851€25,057€23,151€18,866€32,670▲ 73.2%
Tangible fixed assets22/27€29,851€25,057€23,151€18,866€32,670▲ 73.2%
Land and buildings22€26,275€23,251€18,871€14,491€30,294▲ 109%
Plant, machinery and equipment23€220-----
Furniture and vehicles24€3,356€1,806€4,280€4,375€2,376▼ 45.7%
Current assets29/58€305,365€358,989€482,686€591,790€653,783▲ 10.5%
Amounts receivable within one year40/41€53,715€19,661€32,325€47,004€74,763▲ 59.1%
Trade receivables40€13,206-----
Other amounts receivable41€40,508€19,661€32,325€47,004€74,763▲ 59.1%
Current investments50/53€91,000€131,574€327,999€426,977€527,173▲ 23.5%
Cash at bank and in hand54/58€139,358€180,411€95,813€104,827€39,332▼ 62.5%
Deferred charges and accrued income490/1€21,292€27,344€26,549€12,983€12,515▼ 3.6%
Equity and liabilities
Total equity and liabilities10/49€335,215€384,046€505,837€610,656€686,452▲ 12.4%
Equity10/15€296,374€380,833€500,846€606,049€685,619▲ 13.1%
Contributions10/11€12,400€12,400€12,400€12,400€12,400=
Reserves13€283,608€368,067€488,080€593,649€673,219▲ 13.4%
Non-distributable reserves130/1€1,860€1,860----
Reserves not available under the articles1311€1,860€1,860----
Distributable reserves133€281,748€366,207€488,080€593,649€673,219▲ 13.4%
Profit (loss) carried forward14€366€366€366---
Amounts payable17/49€38,841€3,213€4,991€4,607€833▼ 81.9%
Amounts payable within one year42/48€38,841€3,213€4,991€4,593€833▼ 81.9%
Trade debts44€1,323€1,380€2,776€2,378€833▼ 65.0%
Suppliers440/4€1,323€1,380€2,776€2,378€833▼ 65.0%
Taxes, remuneration and social security45€6,634€1,833€2,215€2,215--
Taxes450/3€6,634€1,833€2,215€2,215--
Other amounts payable47/48€30,885-----
Accrued charges and deferred income492/3---€14--
Line20212022202320242025Change
Profit (loss) for the period9904€94,227€84,459€120,014€105,203€79,570▼ 24.4%
+ Depreciation and write-downs630€5,046€6,035€5,871€6,317€7,371▲ 16.7%
Operating cash flow (approximation)€99,273€90,493€125,885€111,520€86,941▼ 22.0%
Investment in fixed assets (approximation)--€1,240-€3,965-€2,032-€21,175▼ 942%
Change in cash-€41,053-€84,598€9,014-€65,496▼ 827%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
19-08
State Gazette act Resignations & appointments · End & cessation
Resignation: FLIES Emeric Alfred Lydia Noël (director) · Appointment: FLIES Emeric Alfred Lydia Noël (liquidator) · Dissolution9 facts ▸
  • General meeting, 31-07-2026
  • Dissolution, 31-07-2026
  • Accounting effect, 31-07-2026
  • Director resignation, FLIES Emeric Alfred Lydia Noël (director)
  • Board rule, vereffenaar, 1
  • Director appointment, FLIES Emeric Alfred Lydia Noël (liquidator)
  • Other statement, schuldeisers, alle schuldeisers volledig kunnen worden terugbetaald
  • Other statement, vergoeding, 0
  • Power of attorney, FLIES Emeric Alfred Lydia Noël
08-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial Liquidity times 6current ratio 784.86
Current ratio from 128.85 to 784.86; short-term debt falls from €4,593 to €833.
29-08
NBB filing Annual accounts filed
fiscal year 2024 · micro schema · 29 days late
2024
22-07
NBB filing Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial Highest result since 2018net €120,014 ▲42.1%
Operating result €176,139, net result €120,014, both a record.
31-12
Financial Equity above €500,000Eq €500,846 ▲31.5%
6 profitable years in a row build equity to €500,846.
02-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 2 days late
2022
31-12
Financial Liquidity times 14current ratio 111.71
Current ratio from 7.86 to 111.71; short-term debt falls from €38,841 to €3,213.
06-09
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 37 days late
2021
18-11
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 110 days late
2020
31-12
Financial Equity above €200,000Eq €234,657 ▲32.1%
3 profitable years in a row build equity to €234,657.
Show earlier events
25-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 25 days late
2019
31-12
Financial Equity above €150,000Eq €177,699 ▲35.1%
2 profitable years in a row build equity to €177,699.
30-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
23-08
NBB filing Annual accounts filed
fiscal year 2017 · micro schema · 23 days late
2017
27-06
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 4 acts read
About the unread acts

Of the 4 Belgian State Gazette acts we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 office holder, last change in 2026

Other functions 1

FLIES Emeric Alfred Lydia Noël
Liquidator · since 31-07-2026
Current
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
3 of this company's 4 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2008
seat establishment The establishment unit on the map
Ground area
152 m²
Building footprint
81 m²
Volume, LiDAR
902 m³
Parcel 11303B0436/00E013, Flanders · tallest building 15.4 m, ±4 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
Generaal Lemanstraat 70, 2600 Antwerpen
General medical practice
since 20082.201.881.291
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11303B0436/00E013 Flanders 152 m² 1 · 81 m² 15.4 m · 4 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Mandate history

1 person since 2026, 1 in office
Show
  • Board
  • Other function
  • began earlier
Mandates per person, with start and end dates
Name Functions and periods
FLIES Emeric Alfred Lydia Noël
  • Director, until 31-07-2026
  • Liquidator, from 31-07-2026 to date
See the board, name and seat on a given date →

Articles of association

Who signs
“6° de inbreng van een vermogensbestanddeel in andere vennootschappen; 7°de inbreng van het volledige vermogen in andere vennootschappen. Deze machtiging, vereist krachtens artikel 2:88, §1 en §2 WVV, wordt hier bijgevolg uitdrukkelijk verleend. Vertegenwoordiging De vereffenaar vertegenwoordigt de…”
Full text

6° de inbreng van een vermogensbestanddeel in andere vennootschappen; 7°de inbreng van het volledige vermogen in andere vennootschappen. Deze machtiging, vereist krachtens artikel 2:88, §1 en §2 WVV, wordt hier bijgevolg uitdrukkelijk verleend. Vertegenwoordiging De vereffenaar vertegenwoordigt de vennootschap in vereffening jegens derden, met inbegrip van de vertegenwoordiging in rechte. Vereffeningsverrichtingen Voor wat de verrichtingen van de vereffening betreft, dient de vereffenaar zich te houden aan de artikelen 2:94. tot en met 2:99. WVV.

Financial year
Other statement
Vereffeningsverrichtingen, artikelen 2:94 tot en met 2:99 WVV
1 more provision on this in the deed

Structure & network

Connections & network

1 current director
Depth

The network starts from this company’s directors. Other companies they run appear here as nodes.

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Similar companies · same sector, comparable size

Of 9,130 companies in sector 86210 we hold annual accounts for 6,337. 4,601 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded30-06-2008
Fiscal year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0898963831
Also 9925:BE0898963831
Registered 24-11-2023

The company is no longer active; its Peppol card can remain until its access point withdraws it.

Register as of 30 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.